The recent analytical report published by Markntel Advisors (a leading consulting, data analytics, and market research firm), Nanomedicine Therapeutics Market comprises a detailed study of critical and major aspects of market dynamics, i.e. market trends, size, forecasts, growth factors, challenges, and competitor landscape.
In-Depth Market Overview of Nanomedicine Therapeutics Industry (2023-2028):
According to the latest report, The Nanomedicine Therapeutics Market is projected to grow at a CAGR of around 12.5% during the forecast period, i.e., 2023-28. The report demonstrates the prominent factors propelling the exponential growth of the Nanomedicine Therapeutics industry.
Key Takeaways: Beneficial for Stakeholders and Clients:
- Historical Data: 2018-21
- Base Year: 2022
- Forecast Period: 2023-28
- CAGR: 12.5%
What are the major Driver the Nanomedicine Therapeutics industry?
Enhanced Adoption of Targeted Nanotherapies for Cancer Treatment – In cancer therapeutics, drugs are designed to affect the cell cycle mechanism, which can be controlled to inhibit the cell division of the tumor cells. Nanomedicines have been in the highest demand among all the available cancer therapeutics, owing to their nature of targeting tumor cells only. Most cancer drugs have been observed to show side effects, including the negative effect of the cell division process of non-tumoral cells. This is not the case in these therapeutics, as they have been found to effectively deliver the drug to the tumoral tissues, thus reducing other side effects caused by conventional drugs.
Henceforth, cancer being one of the major global burdens & causing the largest number of related deaths, the need for upgraded & targeted therapy was much required. Thus, companies like Johnson & Johnson, Teva Pharmaceuticals, etc., have launched & commercialized their cancer nanomedicines during the past few years. These medicines were commercialized on a large scale across Asia-Pacific, Europe, and North America, which has supported the growth of the market. Besides, companies like Celgene, Halozyme Therapeutics, etc., have also been investing in the R&D of targeted Nano therapies for cancer. Thus, these target nano therapies under clinical trials have the potential to create lucrative opportunities for the growth of the Global Nanomedicine Therapeutics Market during 2023-28.
Download a sample PDF of this report to gain insights into the complete report structure – https://www.marknteladvisors.com/query/request-sample/nanomedicine-therapeutics-market.html
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Nanomedicine Therapeutics Market Segmentation
The Nanomedicine Therapeutics Market analysis of Markntel Advisors explores the industry by emphasizing the growth parameters and categorizes including geographical segmentation, to offer a comprehensive understanding of the market dynamic. The further bifurcations are as follows:
- By Application
- Drug Delivery- Market Size & Forecast 2018-2028, USD Million
- Regenerative Medicine- Market Size & Forecast 2018-2028, USD Million
- Vaccines – Market Size & Forecast 2018-2028, USD Million
- Active Implants- Market Size & Forecast 2018-2028, USD Million
- Others (Controlled Drug Release, Combination therapy, etc.) – Market Size & Forecast 2018-2028, USD Million
- By Indication
- Oncology- Market Size & Forecast 2018-2028, USD Million
- Infectious Disease- Market Size & Forecast 2018-2028, USD Million
- Cardiology- Market Size & Forecast 2018-2028, USD Million
- Neurological Disease- Market Size & Forecast 2018-2028, USD Million
- Others (Orthopaedics, Urology, etc.) – Market Size & Forecast 2018-2028, USD Million
- By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific
As per the regional aspect, the Nanomedicine Therapeutics Market is expected to be dominated by North America by capturing the potential market share.
Explore further details about this research report – https://www.marknteladvisors.com/research-library/nanomedicine-therapeutics-market.html
Top Companies in the Nanomedicine Therapeutics Market
Johnson & Johnson Ltd, Bristol-Myers Squibb Company, Ipsen Pharma, GlaxoSmithKline plc, Arrowhead Pharmaceuticals, Inc., Nanospectra Biosciences, Cristal Therapeutics, MagArray, Inc. , BlueWillow Biologics, MagForce NT GmbH, Acrotech Biopharma LLC, Recordati S.p.A., Ratiopharm GmbH, Alnylam Pharmaceuticals., Clene Nanomedicine
Global Nanomedicine Therapeutics Market Recent Development
2022: Clene Nanomedicine announced the phase 2 trial result of its CNM-Au8 drug, which is designed for the treatment of neurodegenerative diseases. The study showed positive results by significantly reducing the disease progression of Amyotrophic Lateral Sclerosis.
2022: Glaxo Smith Kline Plc., has announced that it received prequalification approval from the World Health Organization (WHO) for Mosquirix, which is a liposome-based vaccine for malaria. This vaccine has been allowed to use across countries with a higher prevalence of malaria caused by P. falciparum.
Why Markntel Advisors Report?
Well-known business Prospects: Our accurate analysis market research report serves as a treasure map for discovering potential markets and novel product avenues. Additionally, it facilitates comprehensive comparisons of products and services.
Thoughtful Customer Insights: A market report provides the marketing department with an in-depth understanding of customer requirements and desires. This information is bound to enhance products, adjust pricing, and refine advertising strategies.
Empowering Data-Backed Judgement: Our comprehensive Market research encompasses a wide spectrum of activities, including precise market sizing, detailed segment analysis, accurate demand forecasting, competitor identification, and meticulous pricing trend monitoring.
Need personalized insights? Click here to customize this report- https://www.marknteladvisors.com/query/request-customization/nanomedicine-therapeutics-market.html
For Further Queries:
Contact Us
MarkNtel Advisors
+1 628 895 8081, +91 120 4278433
Corporate Office: Office No.109,
H-159, Sector 63, Noida, Uttar Pradesh – 201281, India
